Gina Fusaro
About Gina Fusaro
Gina Fusaro is the Executive Director and Development Team Lead at Bristol-Myers Squibb, with extensive experience in scientific communications and medical strategy in oncology.
Current Role at Bristol-Myers Squibb
Gina Fusaro is serving as the Executive Director, Development Team Lead at Bristol-Myers Squibb. She has been leading the development team since January 2020, bringing her extensive experience in scientific communications and medical strategy to the role. Focused on oncology, she oversees critical projects aimed at advancing treatments and therapies in this field.
Previous Experience at Celgene
Gina Fusaro accumulated significant experience at Celgene, a biopharmaceutical company. She was the Executive Director of Global Project Leadership from 2016 to 2020, managing global projects and initiatives. Prior to that, she served as Senior Director of Global Scientific Communications, Solid Tumors and Early Compounds, from 2014 to 2016. In earlier roles, she was the Director of Scientific Communications for Solid Tumors from 2011 to 2014 and Manager of Scientific Communications from 2010 to 2011.
Roles at Health Science Communications
Before joining Celgene, Gina Fusaro worked at Health Science Communications from 2004 to 2010. She progressed through various roles starting as Assistant Medical Director (2004-2005), then advancing to Associate Medical Director (2005-2006), and becoming Medical Director from 2007 to 2010. These roles provided her with a substantial grounding in medical strategy and communication.
Educational Background
Gina Fusaro has a strong academic foundation with a Bachelor of Science in Biochemistry from Brown University, where she studied from 1993 to 1997. She furthered her education at Columbia University College of Physicians and Surgeons, earning a PhD in Molecular Biology from 1997 to 2003. Her advanced studies have equipped her with deep expertise in molecular biology, contributing to her proficiency in the oncology field.
Expertise in Oncology
Gina Fusaro has specialized expertise in the field of oncology, underpinned by her academic background and professional roles. Her work at Celgene and Bristol-Myers Squibb has consistently focused on advancing scientific communications and medical strategies within oncology. Her leadership in these areas has been crucial in driving the development of treatments and therapeutic approaches.